MIG Capital has led a €5 million Series A funding round for HawkCell to enhance its veterinary MRI technology and drive international expansion.

Target Information

HawkCell, based in Lyon, France, is a pioneering health technology startup specializing in veterinary MRI solutions. The company has developed a novel plug-and-play MRI system that combines hardware and software optimized for animal health and preclinical research. By utilizing patented 3D-printed MRI coils tailored to animal morphology, HawkCell enhances image quality while minimizing the need for anesthesia, therefore reducing associated risks. Their innovative approach employs AI algorithms for quantification and noise suppression, significantly shortening imaging times while delivering unparalleled image clarity.

HawkCell's mission is to bridge the gap between human and veterinary medicine, providing veterinary professionals with advanced tools that enable more accurate diagnoses and efficient treatment options. As MRI technology has been underutilized in veterinary medicine, HawkCell's advancements represent a significant leap forward, offering invaluable insights into animal health and improving preclinical testing processes.

Industry Overview in France

The veterinary healthcare sector in France is experiencing a transformative phase, fueled by increased spending on pet care and advancements in medical technology. The demand for high-quality veterinary services has surged as pet ownersh